Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
Medical Education Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
BMC Infect Dis. 2020 Oct 19;20(1):777. doi: 10.1186/s12879-020-05511-8.
There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at a national level, and none after 60 days of follow up. The aim of this study was to describe national, 60-day all-cause mortality associated with COVID-19, and to identify risk factors associated with admission to an intensive care unit (ICU).
This was a retrospective cohort study including the first consecutive 5000 patients with COVID-19 in Qatar who completed 60 days of follow up by June 17, 2020. The primary outcome was all-cause mortality at 60 days after COVID-19 diagnosis. In addition, we explored risk factors for admission to ICU.
Included patients were diagnosed with COVID-19 between February 28 and April 17, 2020. The majority (4436, 88.7%) were males and the median age was 35 years [interquartile range (IQR) 28-43]. By 60 days after COVID-19 diagnosis, 14 patients (0.28%) had died, 10 (0.2%) were still in hospital, and two (0.04%) were still in ICU. Fatal COVID-19 cases had a median age of 59.5 years (IQR 55.8-68), and were mostly males (13, 92.9%). All included pregnant women (26, 0.5%), children (131, 2.6%), and healthcare workers (135, 2.7%) were alive and not hospitalized at the end of follow up. A total of 1424 patients (28.5%) required hospitalization, out of which 108 (7.6%) were admitted to ICU. Most frequent co-morbidities in hospitalized adults were diabetes (23.2%), and hypertension (20.7%). Multivariable logistic regression showed that older age [adjusted odds ratio (aOR) 1.041, 95% confidence interval (CI) 1.022-1.061 per year increase; P < 0.001], male sex (aOR 4.375, 95% CI 1.964-9.744; P < 0.001), diabetes (aOR 1.698, 95% CI 1.050-2.746; P 0.031), chronic kidney disease (aOR 3.590, 95% CI 1.596-8.079, P 0.002), and higher BMI (aOR 1.067, 95% CI 1.027-1.108 per unit increase; P 0.001), were all independently associated with increased risk of ICU admission.
In a relatively younger national cohort with a low co-morbidity burden, COVID-19 was associated with low all-cause mortality. Independent risk factors for ICU admission included older age, male sex, higher BMI, and co-existing diabetes or chronic kidney disease.
目前有关新型冠状病毒病 2019(COVID-19)在全国范围内的结局数据有限,且均未随访至 60 天之后。本研究旨在描述 COVID-19 发病后 60 天的全因死亡率,并确定与入住重症监护病房(ICU)相关的危险因素。
这是一项回顾性队列研究,纳入了 2020 年 6 月 17 日之前在卡塔尔完成 60 天随访的前 5000 例连续确诊 COVID-19 的患者。主要结局为 COVID-19 确诊后 60 天的全因死亡率。此外,我们还探讨了入住 ICU 的危险因素。
纳入的患者确诊 COVID-19 的时间为 2020 年 2 月 28 日至 4 月 17 日。大多数患者(4436 例,88.7%)为男性,中位年龄为 35 岁[四分位距(IQR)28-43]。COVID-19 确诊后 60 天,14 例(0.28%)患者死亡,10 例(0.2%)仍在住院,2 例(0.04%)仍在 ICU。死亡的 COVID-19 患者中位年龄为 59.5 岁(IQR 55.8-68),且均为男性(13 例,92.9%)。所有纳入的孕妇(26 例,0.5%)、儿童(131 例,2.6%)和医务人员(135 例,2.7%)在随访结束时均存活且未住院。共有 1424 例(28.5%)患者需要住院治疗,其中 108 例(7.6%)入住 ICU。住院成年患者最常见的合并症为糖尿病(23.2%)和高血压(20.7%)。多变量逻辑回归显示,年龄较大[校正优势比(aOR)1.041,95%置信区间(CI)1.022-1.061,每年增加;P<0.001]、男性(aOR 4.375,95%CI 1.964-9.744;P<0.001)、糖尿病(aOR 1.698,95%CI 1.050-2.746;P=0.031)、慢性肾脏病(aOR 3.590,95%CI 1.596-8.079,P=0.002)和较高的 BMI(aOR 1.067,95%CI 1.027-1.108,每单位增加;P<0.001)与 ICU 入住风险增加独立相关。
在一个相对年轻、合并症负担较低的全国性队列中,COVID-19 导致的全因死亡率较低。入住 ICU 的独立危险因素包括年龄较大、男性、较高的 BMI 以及合并糖尿病或慢性肾脏病。